Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record History shows Revision: v3.5.4 as the latest entry, replacing Revision: v3.5.3 and reflecting an administrative update to the study record's version history.
    Difference
    0.1%
    Check dated 2026-05-14T22:58:20.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The record history now shows a newer revision, v3.5.3, at the top. The previous revision, v3.5.2, is removed from the list, reflecting an update to the study record's revision history.
    Difference
    0.1%
    Check dated 2026-04-30T18:07:14.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.2) has been added to the history, and the older v3.5.0 entry has been removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:08.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:54.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and Revision v3.4.2 was removed from the Study Record Versions.
    Difference
    0.1%
    Check dated 2026-03-11T16:35:51.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 added to the record history; the funding/operating status notice shown in v3.4.1 was removed.
    Difference
    0.9%
    Check dated 2026-02-11T06:16:34.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.